"This bipartisan legislation will eliminate the pill penalty and help ensure science and researchers – not government bureaucrats – determine the possible treatments innovator companies pursue," said BIO CEO and president John Crowley.
US biotech industry welcomes proposed change to price negotiation power
February 27, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Rare Cancers welcomes future funding for 'game-changing' cancer service
February 27, 2025 - - Latest News -
US biotech industry welcomes proposed change to price negotiation power
February 27, 2025 - - Latest News -
HTA go-slow on newborn screening leaves parents waiting and waiting
February 27, 2025 - - Latest News -
Officials blame companies for not highlighting quality of life benefits
February 26, 2025 - - Latest News -
US FDA accepts application for Telix's Zircaix and grants priority review
February 26, 2025 - - Australian Biotech -
Arovella receives commitments for $15 million following cancellation of January placement
February 26, 2025 - - Australian Biotech -
MTPConnect refreshes board with new appointment and retirement
February 26, 2025 -